Organo-ID provides preclinical models for metabolic liver disease and rare diseases such as citrullinemia and pyruvate decarboxylase. Additionally, they provide PDCOs that can test tumor response to treatments for individual patients and report on their results, which increases the chances of oncologists treating patients in a more personalized